Image by National Institute of Allergy and Infectious Diseases

About Us

The Peer’s lab works at the interface of materials science, chemistry, molecular biology, and immunology, aiming to discover and validate novel therapeutic targets at the molecular level, and to develop targeted genetic medicines for therapeutic applications and disease management. The lab is highly dynamic, multidisciplinary, focusing on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi , mRNA, saRNA, cirRNA, DNA, and novel genome editing strategies.

The lab goal is to translate academic discoveries into innovative therapeutic modalities. With that in mind, Prof. Peer also founded SPARK Tel Aviv to accelerate cures via academic discoveries. Prof. Peer strives to develop the career of young students and encourage them to fulfill their ambitions and dreams.

Active Team ⮞

Prof. Dan Peer

Dan Peer is the director of the Laboratory of Precision NanoMedicine at Tel Aviv University. He is also the Vice President for Research and Development at Tel Aviv University. His lab works in the interface of basic and translational science. In addition, Prof. Peer is the Founder and Managing Director of the SPARK Tel Aviv, Center for Translational Medicine.

Moreover, Prof. Peer is on the Scientific Advisory Board of numerous international companies and an invited keynote speaker at many conferences. In 2014, he was elected to the Israel Young Academy.

In 2023, he was elected to the US National Academy of Engineering. In 2024, he was elected as a Fellow of the US National Academy of Inventors.

In 2026, Prof. Dan Peer was awarded the Rapport Prize for excellence in biomedical science and the Landau Prize for excellence in nanotechnology.

email: peer@tauex.tau.ac.il

Leave a Message